David M Smadja
Overview
Explore the profile of David M Smadja including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
180
Citations
4109
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gendron N, Planquette B, Roche A, Chocron R, Helley D, Philippe A, et al.
Stem Cell Rev Rep
. 2025 Mar;
PMID: 40085375
Pulmonary embolism (PE) is a life-threatening condition with long-term complications, including residual pulmonary vascular obstruction (RPVO). RPVO is associated with an increased risk of venous thromboembolism recurrence, chronic symptoms, and...
2.
3.
Smadja D, Berkane Y, Bentounes N, Rancic J, Cras A, Pinault C, et al.
Angiogenesis
. 2025 Mar;
28(2):19.
PMID: 40047974
Cord blood-derived endothelial colony-forming cells (CB-ECFCs) hold significant promise for regenerative medicine due to their unique vasculogenic and immunomodulatory properties. These cells exhibit a superior proliferative capacity, robust ability to...
4.
Smadja D, Roux de Bezieux J, Peronino C, Jilet L, Ivak P, Pya Y, et al.
ASAIO J
. 2025 Feb;
PMID: 40019017
This study aimed to assess platelet activation following implantation of the Aeson bioprosthetic total artificial heart (A-TAH). We monitored plasma levels of platelet activation markers in patients receiving A-TAH support...
5.
El Hamaoui D, Marchelli A, Gandrille S, Reboul E, Stepanian A, Palmier B, et al.
Commun Biol
. 2025 Feb;
8(1):316.
PMID: 40011679
Increased levels of soluble endoglin (sEng) are found in serum, plasma, and urine of preeclampsia patients. sEng is released from membrane-bound endoglin through the proteolytic activity of metalloproteases, but its...
6.
Rosa M, Dupont A, Smadja D, Soquet J, Abdoul J, Pamart T, et al.
Circulation
. 2025 Feb;
PMID: 39989358
Background: To date, the only effective treatment of severe aortic stenosis is valve replacement. With the introduction of transcatheter aortic valve replacement and extending indications to younger patients, the use...
7.
Dawudi Y, Benarroch S, Helfer H, Smadja D, Mahe I
Res Pract Thromb Haemost
. 2025 Feb;
9(1):102667.
PMID: 39980606
Janus kinase inhibitors (JAKis) have revolutionized the treatment landscape for various inflammatory and autoimmune diseases since their introduction in 2012. The expanded indications of JAKis have raised concerns about the...
8.
Smadja D, Abreu M
Front Neurosci
. 2025 Feb;
19:1475376.
PMID: 39967803
Neurodegenerative diseases (NDs) and Long COVID represent critical and growing global health challenges, characterized by complex pathophysiological mechanisms including neuronal deterioration, protein misfolding, and persistent neuroinflammation. The emergence of innovative...
9.
Vannini M, Schved J, Smadja D, Jung V, Mauge L, Sanchez O, et al.
Res Pract Thromb Haemost
. 2025 Jan;
9(1):102647.
PMID: 39810982
The question of whether scuba diving is safe for patients with a history of venous thromboembolism (VTE) remains unanswered. Cases of VTE have been reported after decompression accidents but not...
10.
Schroder J, McCartney S, Jansen P, Plichta R, Katz J, Smadja D, et al.
Ann Thorac Surg Short Rep
. 2025 Jan;
1(1):185-187.
PMID: 39790550
The Aeson total artificial heart provides right- and left-sided heart replacement for biventricular failure with notable improvements from prior generations. These include enhanced hemocompatibility and autoregulation enabling increased output in...